Octapharma (IP): what changed
Octapharma (IP)
Largest movements
- Cash +€11,376
up €11,376 (+25.3%), from €44,926 to €56,302
mainly Net result for the year (+€5,089) and Other debts (+€4,236)
- Profit (loss) carried forward +€5,089
up €5,089 (+22.0%), from €23,133 to €28,221
- Other debts +€4,236
up €4,236 (+384%), from €1,104 to €5,340
- Tax, wage and social debts +€1,852
up €1,852 (+115%), from €1,608 to €3,460
- Gross operating margin +€1,000
up €1,000 (+14.5%), from €6,876 to €7,876
- Taxes +€245
up €245 (+15.2%), from €1,608 to €1,852
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,926 | €56,302 | +€11,376 | +25.3% |
| Current assets | 29/58 | €44,926 | €56,302 | +€11,376 | +25.3% |
| Cash at bank and in hand | 54/58 | €44,926 | €56,302 | +€11,376 | +25.3% |
| Total equity and liabilities | 10/49 | €44,926 | €56,302 | +€11,376 | +25.3% |
| Equity | 10/15 | €35,533 | €40,621 | +€5,089 | +14.3% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Profit (loss) carried forward | 14 | €23,133 | €28,221 | +€5,089 | +22.0% |
| Amounts payable | 17/49 | €9,393 | €15,681 | +€6,287 | +66.9% |
| Amounts payable within one year | 42/48 | €9,393 | €15,681 | +€6,287 | +66.9% |
| Trade debts | 44 | €6,682 | €6,881 | +€199 | +3.0% |
| Suppliers | 440/4 | €6,682 | €6,881 | +€199 | +3.0% |
| Taxes, remuneration and social security | 45 | €1,608 | €3,460 | +€1,852 | +115% |
| Taxes | 450/3 | €1,608 | €3,460 | +€1,852 | +115% |
| Other amounts payable | 47/48 | €1,104 | €5,340 | +€4,236 | +384% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €6,876 | €7,876 | +€1,000 | +14.5% |
| Operating profit (loss) | 9901 | €6,489 | €7,476 | +€987 | +15.2% |
| Financial charges | 65/66B | €589 | €535 | -€54 | -9.2% |
| Recurring financial charges | 65 | €589 | €535 | -€54 | -9.2% |
| Profit (loss) for the period before taxes | 9903 | €5,900 | €6,941 | +€1,041 | +17.6% |
| Income taxes | 67/77 | €1,608 | €1,852 | +€245 | +15.2% |
| Profit (loss) for the period | 9904 | €4,292 | €5,089 | +€797 | +18.6% |
| Profit (loss) for the period to be appropriated | 9905 | €4,292 | €5,089 | +€797 | +18.6% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.